A: It wouldn’t be a core stock in my portfolio ( I just don’t really like the industry). According to the brokers, a little overvalued. Consensus target price is $14.73, about 4.2% lower than the last ASX price. Trading on a multiple of 32.7 times forecast FY21 earnings, 27.8 times forecast FY22 earnings.